Raymond James & Associates’s LivaNova LIVN Stock Holding History

Raymond James & Associates’s Portfolio LIVN Stock Details LIVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$238K	Buy	+4,528	New	+$224K	﹤0.01%	3541
2018 Q2	–	Sell	-2,745	Closed	-$243K	–	3640
2018 Q1	$243K	Buy	+2,745	New	+$234K	﹤0.01%	3029
2016 Q4	–	Sell	-8,480	Closed	-$510K	–	3311
2016 Q3	$510K	Buy	8,480 +3,835	+83%	+$221K	﹤0.01%	2271
2016 Q2	$233K	Buy	+4,645	New	+$235K	﹤0.01%	2564

Other funds holding LIVN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Raymond James & Associates's LIVN Position: Q3 2024 in Review

Raymond James & Associates opened a new position in LivaNova (LIVN) in Q3 2024: 4,528 shares worth $238K. The stake represents ﹤0.01% of the portfolio and ranks #3541 among its holdings. This is a return to the name: Raymond James & Associates previously reported a position in LIVN as recently as Q1 2018.

Raymond James & Associates first reported a position in LIVN in Q2 2016 and has held it in 4 quarters since. The position peaked at $510K in Q3 2016. 243 funds tracked by Wall St. Rank hold LIVN as of Q3 2024.

Raymond James & Associates held 4,528 shares of LivaNova worth $238K as of Q3 2024.
LivaNova was a new Raymond James & Associates position in Q3 2024.
LivaNova made up ﹤0.01% of Raymond James & Associates's portfolio in Q3 2024, its #3541 holding.
Raymond James & Associates first reported a position in LivaNova in Q2 2016 and has held it in 4 quarters since.
Raymond James & Associates's LivaNova position peaked at $510K in Q3 2016.
243 funds tracked by Wall St. Rank held LivaNova as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.